I was wondering if anyone have develop effective strategies for:
- Preventing confusion between conventional and lipid-based (liposomal) products of the same drug product. I know some people have dealt with amphotericin B vs. liposomal amphotericin B by only stocking one agent, but am curious about what people have done when both products are needed (like chemo).
- Getting nurses to NOT dilute drugs on the patient care unit that do not require dilution?
If you feel that you have a good process for either of these two issues, I would appreciate if you would respond in this forum or send me a separate email at email@example.com. I would like to talk with you about what you have done.